Brief: Pixium Vision Says Decided To Postpone Continuing Feasibility Studies In France And US
23/03/2020 17:48
March 23 (Reuters) - Pixium Vision SA ALPIX.PA :
* PIXIUM VISION SA - PROVIDES UPDATE ON COVID-19 IMPACT
* PIXIUM VISION SA - DECIDED TO POSTPONE CONTINUING ITS
FEASIBILITY STUDIES IN FRANCE AND US, WITH EXCEPTION OF ONGOING
SAFETY MONITORING.
* PIXIUM VISION SA - INITIATION OF PRIMAVERA PIVOTAL STUDY
WITH
PRIMA SYSTEM IN DRY AGE-RELATED MACULAR DEGENERATION (AMD) MAY
BE DELAYED
* PIXIUM VISION SA - WILL SEEK NON-DILUTIVE FINANCING,
INCLUDING
THROUGH COMMERCIAL BANK LOANS
* PIXIUM VISION SA - SHOULD COVID-19 CRISIS SITUATION
PERSIST
COMPANY WILL LOOK AT ALTERNATIVES IN ORDER TO REDUCE CASH BURN
Source text for Eikon: ID:nGNE15NN1G
Further company coverage: ALPIX.PA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pixium Vision SA
See all newsBrief: Pixium Vision SA Says Paris Commercial Court Postponed Decision On Takeover Offer Filed On Nov 20, 2023
Brief: Pixium Vision: opening of judicial liquidation proceedings has been postponed to later date
Brief: Pixium Vision Announces Decision About Adoption Of Sale Plan, Opening Of Judicial Liquidation Proceedings Planned For Jan 16, 2024
Brief: Pixium Vision SA Announces Conversion Of Safeguard Proceedings Into Receivership
Brief: Pixium Vision Announces Tender Process For Purpose Of Finding Buyers To Acquire Company's Business Will Be Published Tomorrow